ÂÜÀòÂÒÂ×

Jim Brandt is an accomplished investor currently involved with several companies including iPourIt, Rain Neuromorphics, Gaingels Holdings, Alleviate Inc, JUAD Neurotech, Devyce, Rotender (Techstars '22), Carta, Arima Genomics, and Immunis, Inc, with investment roles beginning as early as December 2021 and continuing through December 2023. Jim Brandt holds a JD in Law from Columbia Law School and a BA in Political Science and Government from Northwestern University, complemented by a diploma from Scarsdale High School.